Nitazoxanide Therapy for Patients With COVID-19 Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

April 19, 2020

Primary Completion Date

October 2, 2020

Study Completion Date

October 2, 2020

Conditions
Covid19Corona Virus InfectionPneumonia, Viral
Interventions
DRUG

Nitazoxanide

Nitazoxanide 500mg three times a day for 5 days

DRUG

Placebo

Placebo three times a day for 5 days

Trial Locations (1)

21941902

Universidade Federal do Rio de Janeiro, Rio de Janeiro

All Listed Sponsors
collaborator

Ministry of Science and Technology, Brazil

OTHER

collaborator

National Research Council, Brazil

OTHER

collaborator

Financiadora de Estudos e Projetos

OTHER

collaborator

ATCGen

UNKNOWN

collaborator

Hospital Central da Aeronáutica, Rio de Janeiro

UNKNOWN

collaborator

Hospital da Força Aérea do Galeão

UNKNOWN

collaborator

Hospital Naval Marcilio Dias

UNKNOWN

collaborator

Hospital Universitario Pedro Ernesto

OTHER

collaborator

Hospital de Força Aérea de São Paulo

UNKNOWN

collaborator

Hospital das Clínicas Luzia de Pinho Melo

UNKNOWN

collaborator

Complexo Hospitalar Municipal de São Caetano do Sul

UNKNOWN

collaborator

Hospital Municipal de Barueri Dr Francisco Moran

UNKNOWN

collaborator

Hospital Regional de Sorocaba Dr Adib Domingos Jatene

UNKNOWN

collaborator

Hospital Geral de São Mateus Dr Manoel Bifulco

UNKNOWN

collaborator

Santa Casa de Misericórdia de Belo Horizonte

OTHER

collaborator

Mater Dei Hospital, Brazil

OTHER

collaborator

Hospital Eduardo de Menezes

UNKNOWN

collaborator

Hospital das Clínicas da Universidade Federal de Pernambuco

UNKNOWN

collaborator

Hospital das Forças Armadas, Brazil

OTHER

collaborator

Hospital Regional da Asa Norte, Brazil

UNKNOWN

collaborator

Complexo Hospitalar do Trabalhador de Curitiba

UNKNOWN

collaborator

Hospital Estadual de Doenças Tropicais Dr Anuar Auad

UNKNOWN

collaborator

Hospital Geral de Fortaleza

OTHER_GOV

lead

Universidade Federal do Rio de Janeiro

OTHER

NCT04561219 - Nitazoxanide Therapy for Patients With COVID-19 Pneumonia | Biotech Hunter | Biotech Hunter